AAAAAA

   
Results: 1-8 |
Results: 8
EVALUATION OF MONOCLONAL-ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PRIMARY ISOLATES BY NEUTRALIZATION ASSAYS - PERFORMANCE CRITERIAFOR SELECTING CANDIDATE ANTIBODIES FOR CLINICAL-TRIALS
Authors: DSOUZA MP LIVNAT D BRADAC JA BRIDGES SH BRYSON Y HANSON C MATTHEWS T MOORE J TRKOLA A ZOLLAPAZNER S GORNY M BURTON D MERIGAN T MCNAMARA J NORCROSS M POSNER M ROBINSON J VIRANIKETTER N BARBAS C PARREN P KATINGER H
Citation: Mp. Dsouza et al., EVALUATION OF MONOCLONAL-ANTIBODIES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PRIMARY ISOLATES BY NEUTRALIZATION ASSAYS - PERFORMANCE CRITERIAFOR SELECTING CANDIDATE ANTIBODIES FOR CLINICAL-TRIALS, The Journal of infectious diseases, 175(5), 1997, pp. 1056-1062
HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE CODON-215 MUTATIONS DIMINISH VIROLOGICAL RESPONSE TO DIDANOSINE-ZIDOVUDINE THERAPY IN SUBJECTS WITH NON-SYNCYTIUM-INDUCING PHENOTYPE
Authors: HOLODNIY M KATZENSTEIN D MOLE L WINTERS M MERIGAN T
Citation: M. Holodniy et al., HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE CODON-215 MUTATIONS DIMINISH VIROLOGICAL RESPONSE TO DIDANOSINE-ZIDOVUDINE THERAPY IN SUBJECTS WITH NON-SYNCYTIUM-INDUCING PHENOTYPE, The Journal of infectious diseases, 174(4), 1996, pp. 854-857
THE TOLERABILITY AND PHARMACOKINETICS OF N-BUTYL-DEOXYNOJIRIMYCIN IN PATIENTS WITH ADVANCED HIV DISEASE (ACTG-100)
Authors: TIERNEY M POTTAGE J KESSLER H FISCHL M RICHMAN D MERIGAN T POWDERLY W SMITH S KARIM A SHERMAN J HIRSCH M
Citation: M. Tierney et al., THE TOLERABILITY AND PHARMACOKINETICS OF N-BUTYL-DEOXYNOJIRIMYCIN IN PATIENTS WITH ADVANCED HIV DISEASE (ACTG-100), Journal of acquired immune deficiency syndromes and human retrovirology, 10(5), 1995, pp. 549-553
SAFETY, PHARMACOKINETICS, AND ANTIVIRAL RESPONSE OF CD4-IMMUNOGLOBULIN-G BY INTRAVENOUS BOLUS IN AIDS AND AIDS-RELATED COMPLEX
Authors: COLLIER AC COOMBS RW KATZENSTEIN D HOLODNIY M GIBSON J MORDENTI J IZU AE DULIEGE AM AMMANN AJ MERIGAN T COREY L
Citation: Ac. Collier et al., SAFETY, PHARMACOKINETICS, AND ANTIVIRAL RESPONSE OF CD4-IMMUNOGLOBULIN-G BY INTRAVENOUS BOLUS IN AIDS AND AIDS-RELATED COMPLEX, Journal of acquired immune deficiency syndromes and human retrovirology, 10(2), 1995, pp. 150-156
INDIVIDUALIZATION OF THERAPY USING VIRAL MARKERS
Authors: MERIGAN T
Citation: T. Merigan, INDIVIDUALIZATION OF THERAPY USING VIRAL MARKERS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 41-46
ROLE OF HIV ANTIGEN-PULSED DENDRITIC CELLS ON THE IMMUNOTHERAPY OF AIDS
Authors: BENIKE CJ HSU F LEVY R KUNDU S MERIGAN T ENGLEMAN EG
Citation: Cj. Benike et al., ROLE OF HIV ANTIGEN-PULSED DENDRITIC CELLS ON THE IMMUNOTHERAPY OF AIDS, AIDS research and human retroviruses, 11, 1995, pp. 172-172
ZIDOVUDINE AND DIDEOXYCYTIDINE DIFFER IN THEIR EFFECTS ON HUMAN IMMUNODEFICIENCY VIRUS-INDUCED PATHOLOGICAL ACTIVATION OF THE IMMUNE-SYSTEM
Authors: LIU M FAHEY JL AZIZ N CUMBERLAND WG SKOWRON G MERIGAN T
Citation: M. Liu et al., ZIDOVUDINE AND DIDEOXYCYTIDINE DIFFER IN THEIR EFFECTS ON HUMAN IMMUNODEFICIENCY VIRUS-INDUCED PATHOLOGICAL ACTIVATION OF THE IMMUNE-SYSTEM, The Journal of infectious diseases, 170(5), 1994, pp. 1165-1171
CD(4) RESPONSE TO ANTIVIRAL THERAPY IN HIV(+) HEMOPHILIC MEN
Authors: RAGNI M AMATO D LOFARO M KORVICK J MERIGAN T
Citation: M. Ragni et al., CD(4) RESPONSE TO ANTIVIRAL THERAPY IN HIV(+) HEMOPHILIC MEN, Blood, 82(10), 1993, pp. 10000413-10000413
Risultati: 1-8 |